These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26868993)

  • 21. Altered FoxO3 expression and apoptosis in granulosa cells of women with polycystic ovary syndrome.
    Mikaeili S; Rashidi BH; Safa M; Najafi A; Sobhani A; Asadi E; Abbasi M
    Arch Gynecol Obstet; 2016 Jul; 294(1):185-92. PubMed ID: 26993517
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CiRS-126 inhibits proliferation of ovarian granulosa cells through targeting the miR-21-PDCD4-ROS axis in a polycystic ovarian syndrome model.
    Lu J; Xue Y; Wang Y; Ding Y; Zou Q; Pan M; Qiao L; Zhang C; Ge Q; Wang T; Li H
    Cell Tissue Res; 2020 Jul; 381(1):189-201. PubMed ID: 32468088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
    Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
    J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance and β-cell dysfunction and the relationship with cardio-metabolic disorders among women with polycystic ovary syndrome.
    Mu L; Zhao Y; Lai Y; Li R; Qiao J
    Clin Endocrinol (Oxf); 2018 Dec; 89(6):779-788. PubMed ID: 30106166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
    Yildizhan R; Ilhan GA; Yildizhan B; Kolusari A; Adali E; Bugdayci G
    Fertil Steril; 2011 Jul; 96(1):246-50. PubMed ID: 21600576
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin resistance and its relationship with high molecular weight adiponectin in adolescents with polycystic ovary syndrome and a maternal history of polycystic ovary syndrome.
    Cankaya S; Demir B; Aksakal SE; Dilbaz B; Demirtas C; Goktolga U
    Fertil Steril; 2014 Sep; 102(3):826-30. PubMed ID: 24973036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered composition of high density lipoproteins in women with the polycystic ovary syndrome.
    Rajkhowa M; Neary RH; Kumpatla P; Game FL; Jones PW; Obhrai MS; Clayton RN
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3389-94. PubMed ID: 9329374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.
    Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A
    Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High plasma level of long Pentraxin 3 is associated with insulin resistance in women with polycystic ovary syndrome.
    Aydogdu A; Tasci I; Tapan S; Basaran Y; Aydogan U; Meric C; Sonmez A; Aydogdu S; Akbulut H; Taslipinar A; Uckaya G; Azal O
    Gynecol Endocrinol; 2012 Sep; 28(9):722-5. PubMed ID: 22304663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The relationship between glomerular filtration rate, and metabolic and inflammatory parameters in obese and non-obese patients with polycystic ovary syndrome.
    Can M; Duran C; Guney I; Elmas H; Ayhan M; Erdem SS
    Clin Investig Arterioscler; 2020; 32(6):256-262. PubMed ID: 32773256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression and regulation of adipocyte fatty acid binding protein in granulosa cells and its relation with clinical characteristics of polycystic ovary syndrome.
    Hu W; Qiao J
    Endocrine; 2011 Oct; 40(2):196-202. PubMed ID: 21720879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment.
    DeUgarte CM; Bartolucci AA; Azziz R
    Fertil Steril; 2005 May; 83(5):1454-60. PubMed ID: 15866584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive assessment the expression of core elements related to IGFIR/PI3K pathway in granulosa cells of women with polycystic ovary syndrome.
    He T; Liu Y; Zhao S; Liu H; Wang Z; Shi Y
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():134-140. PubMed ID: 30594023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of insulin resistance in lean women with polycystic ovary syndrome.
    Morciano A; Romani F; Sagnella F; Scarinci E; Palla C; Moro F; Tropea A; Policola C; Della Casa S; Guido M; Lanzone A; Apa R
    Fertil Steril; 2014 Jul; 102(1):250-256.e3. PubMed ID: 24825420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adipocyte fatty acid-binding protein is associated with markers of obesity, but is an unlikely link between obesity, insulin resistance, and hyperandrogenism in polycystic ovary syndrome women.
    Möhlig M; Weickert MO; Ghadamgadai E; Machlitt A; Pfüller B; Arafat AM; Pfeiffer AF; Schöfl C
    Eur J Endocrinol; 2007 Aug; 157(2):195-200. PubMed ID: 17656598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can serum apolipoprotein C-I demonstrate metabolic abnormality early in women with polycystic ovary syndrome?
    Huang S; Qiao J; Li R; Wang L; Li M
    Fertil Steril; 2010 Jun; 94(1):205-10. PubMed ID: 19368908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity and inflammatory biomarkers in women with polycystic ovary syndrome.
    Shen SH; Shen SY; Liou TH; Hsu MI; Chang YC; Cheng CY; Hsu CS; Tzeng CR
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():66-71. PubMed ID: 26177495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifestyle intervention up-regulates gene and protein levels of molecules involved in insulin signaling in the endometrium of overweight/obese women with polycystic ovary syndrome.
    Ujvari D; Hulchiy M; Calaby A; Nybacka Å; Byström B; Hirschberg AL
    Hum Reprod; 2014 Jul; 29(7):1526-35. PubMed ID: 24842895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome.
    Sam S; Scoccia B; Yalamanchi S; Mazzone T
    Hum Reprod; 2015 Jun; 30(6):1358-64. PubMed ID: 25857311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.